Cargando…
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
To examine the role of endothelial heparan sulfate during angiogenesis, we generated mice bearing an endothelial-targeted deletion in the biosynthetic enzyme N-acetylglucosamine N-deacetylase/N-sulfotransferase 1 (Ndst1). Physiological angiogenesis during cutaneous wound repair was unaffected, as wa...
Autores principales: | Fuster, Mark M., Wang, Lianchun, Castagnola, Janice, Sikora, Lyudmila, Reddi, Krisanavane, Lee, Phillip H.A., Radek, Katherine A., Schuksz, Manuela, Bishop, Joseph R., Gallo, Richard L., Sriramarao, P., Esko, Jeffrey D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064806/ https://www.ncbi.nlm.nih.gov/pubmed/17470635 http://dx.doi.org/10.1083/jcb.200610086 |
Ejemplares similares
-
Heparan Sulfate Proteoglycans in Tauopathy
por: Zhu, Yanan, et al.
Publicado: (2022) -
Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis
por: Cole, Claire L., et al.
Publicado: (2010) -
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
por: Thieker, David F., et al.
Publicado: (2018) -
Author Correction: Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
por: Thieker, David F., et al.
Publicado: (2020) -
The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
por: Mah, Dylan, et al.
Publicado: (2021)